Okazaki, Taku
The University of Tokyo,
Japan
2025 Rank: 55284
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1056 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55284 | 58751 |
| Total Cites | 1595 | 1619 |
| H-index | 21 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 286 | 288 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 656 | 666 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1172 | 1181 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.37 |
| Self-Citation Percentage |
1.48%
|
|
Okazaki, Taku
The University of Tokyo,
Japan
2024 Rank: 52918
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1072 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52918 | 61014 |
| Total Cites | 1576 | 1605 |
| H-index | 20 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 272 | 280 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 614 | 623 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1151 | 1161 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.38 |
| Self-Citation Percentage |
1.81%
|
|
Okazaki, Taku
The University of Tokyo,
Japan
2023 Rank: 45527
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1008 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45527 | 52259 |
| Total Cites | 1761 | 1803 |
| H-index | 21 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 329 | 340 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 606 | 625 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1282 | 1297 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.39 |
| Self-Citation Percentage |
2.33%
|
|
Okazaki, Taku
The University of Tokyo,
Japan
2022 Rank: 42824
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1093 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42824 | 48417 |
| Total Cites | 1935 | 1994 |
| H-index | 21 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 379 | 394 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 608 | 641 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1378 | 1386 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.44 |
| Self-Citation Percentage |
2.96%
|
|
Okazaki, Taku
The University of Tokyo,
Japan
2021 Rank: 55616
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1293 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55616 | 63133 |
| Total Cites | 2756 | 2801 |
| H-index | 22 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 540 | 546 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 823 | 832 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1958 | 1973 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.42 |
| Self-Citation Percentage |
1.61%
|
|
Okazaki, Taku
Tokushima University,
Japan
2020 Rank: 46746
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1012 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46746 | 52351 |
| Total Cites | 2145 | 2240 |
| H-index | 20 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 438 | 465 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 552 | 598 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1467 | 1492 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.50 |
| Self-Citation Percentage |
4.24%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.